Table 1.
Sample characteristics among opioid maintenance treatment patients in Malmo, Sweden (N = 73).
| Characteristic | n (%) | Median years (range) |
|---|---|---|
| Sex | ||
| Male | 47 (64%) | |
| Female | 22 (30%) | |
| Transgender/do not wish to define | 4 (6%) | |
| Age in years | 43 (22–66) | |
| OMT medication | ||
| Methadone | 42 (58%) | |
| Buprenorphine or buprenorphine-naloxone | 27 (37%) | |
| Missing | 4 (5%) | |
| Years in OMT | 2 (0–8) | |
| Missing n = 8 | ||
| Illicit drug use in the last 30 days before OMT start | ||
| Heroin | 63 (86%) | |
| Cannabis | 29 (40%) | |
| Cocaine | 23 (32%) | |
| Amphetamine | 18 (25%) | |
| Nonmedical prescription drug use in the last 30 days before OMT start | ||
| Benzodiazepines | 41 (56%) | |
| Methadone | 28 (38%) | |
| Other prescription opioids | 28 (38%) | |
| Buprenorphine | 18 (25%) | |
| Prescription stimulants | 10 (14%) |